UniProtKB/SwissProt variant VAR

Variant information

Variant position:

155

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LB/B

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glutamate (E) to Aspartate (D) at position 155 (E155D, p.Glu155Asp).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and acidic.

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

2

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Other resources:

Links to websites of interest for the variant.

Variant rs139923590 [ dbSNP | Ensembl ]

Sequence information

Variant position:

155

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

200

The length of the canonical sequence.

Location on the sequence:

EQGQLLTPEEVVDRIFLLVD E NGDGQLSLNEFVEGARRDKW

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         EQGQLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARRDKW

Mouse                         HQGQLLTPEEVVDRIFLLVDENGDGQLSLTEFIEGARRDKW

Bovine                        QQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARRDKW

Chicken                       ERTPLLTPEEVVDRIFQLVDENGDGQLSLDEFIDGARKDKW

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	2 – 200	Guanylyl cyclase-activating protein 2
Domain	141 – 176	EF-hand 4
Metal binding	154 – 154	Calcium 3
Metal binding	156 – 156	Calcium 3
Metal binding	158 – 158	Calcium 3
Metal binding	160 – 160	Calcium 3
Metal binding	165 – 165	Calcium 3

Literature citations

Genetic analysis of the guanylate cyclase activator 1B (GUCA1B) gene in patients with autosomal dominant retinal dystrophies.
Payne A.M.; Downes S.M.; Bessant D.A.R.; Plant C.; Moore T.; Bird A.C.; Bhattacharya S.S.;
J. Med. Genet. 36:691-693(1999)
Cited for: VARIANT ASP-155;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9UMX6: Variant p.Glu155Asp